Featured Publications

Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study.

Am J Kidney Dis. 2020 Jan;75(1):105-113. doi: 10.1053/j.ajkd.2019.05.022. Epub 2019 Aug 28. PMID: 31473019

A randomized, controlled, behavioral intervention to promote walking after abdominal organ transplantation: results from the LIFT study

Serper M, Barankay I, Chadha S, Shults J, Jones LS, Olthoff KM, Reese PP. A randomized, controlled, behavioral intervention to promote walking after abdominal organ transplantation: results from the LIFT study. Transpl Int. 2020 Jun;33(6):632-643. doi: 10.1111/tri.13570. Epub 2020 Feb 12. PMID: 31925833; PMCID: PMC7239718.

End-of-Life Care among US Adults with ESKD Who Were Waitlisted or Received a Kidney Transplant, 2005-2014

Butler CR, Reese PP, Perkins JD, Hall YN, Curtis JR, Kurella Tamura M, O'Hare AM. End-of-Life Care among US Adults with ESKD Who Were Waitlisted or Received a Kidney Transplant, 2005-2014. J Am Soc Nephrol. 2020 Oct;31(10):2424-2433. doi: 10.1681/ASN.2020030342. Epub 2020 Sep 9. PMID: 32908000; PMCID: PMC7608994.

Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial

Reese PP, Bloom RD, Trofe-Clark J, Mussell A, Leidy D, Levsky S, Zhu J, Yang L, Wang W, Troxel A, Feldman HI, Volpp K. Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial. Am J Kidney Dis. 2017 Mar;69(3):400-409. doi: 10.1053/j.ajkd.2016.10.017. Epub 2016 Dec 7. PMID: 27940063.

Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes

Reese PP, Kessler JB, Doshi JA, Friedman J, Mussell AS, Carney C, Zhu J, Wang W, Troxel A, Young P, Lawnicki V, Rajpathak S, Volpp K. Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes. J Gen Intern Med. 2016 Apr;31(4):402-10. doi: 10.1007/s11606-015-3540-y. PMID: 26585957; PMCID: PMC4803690.

Effect of Financial Incentives for Process, Outcomes, or Both on Cholesterol Level Change: A Randomized Clinical Trial

Reese PP, Barankay I, Putt M, Russell LB, Yan J, Zhu J, Huang Q, Loewenstein G, Andersen R, Testa H, Mussell AS, Pagnotti D, Wesby LE, Hoffer K, Volpp KG. Effect of Financial Incentives for Process, Outcomes, or Both on Cholesterol Level Change: A Randomized Clinical Trial. JAMA Netw Open. 2021 Oct 1;4(10):e2121908. doi: 10.1001/jamanetworkopen.2021.21908. PMID: 34605920; PMCID: PMC8491106.

A randomized, controlled, prehabilitation intervention to maximize early recovery (PRIMER) in liver transplantation

Serper M, Jones LS, Clement T, Reddy RK, Reese PP. A randomized, controlled, prehabilitation intervention to maximize early recovery (PRIMER) in liver transplantation. Liver Transpl. 2024 Jan 1;30(1):10-19. doi: 10.1097/LVT.0000000000000198. Epub 2023 Jun 29. PMID: 37379030; PMCID: PMC10755068.

Transplanting Hepatitis C–Positive Kidneys

Peter P. Reese, M.D., M.S.C.E., Peter L. Abt, M.D., Emily A. Blumberg, M.D., and David S. Goldberg, M.D., M.S.C.E. July 23, 2015 N Engl J Med 2015;373:303-305 DOI: 10.1056/NEJMp1505074 VOL. 373 NO. 4

Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy Era

Schaubel DE, Tran AH, Abt PL, Potluri VS, Goldberg DS, Reese PP. Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy Era. JAMA. 2022 Sep 20;328(11):1102-1104. doi: 10.1001/jama.2022.12868. PMID: 35994263; PMCID: PMC9396466.

Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients: A Single-Group Trial

Peter P. Reese, MD, MSCE, Peter L. Abt, MD, Emily A. Blumberg, MD, Vivianna M. Van Deerlin, MD, PhD, Roy D. Bloom, MD, Vishnu S. Potluri, MD, MPH, Matthew Levine, MD, PhD, David S. Goldberg, MD, MSCE Publication: Annals of Internal Medicine Volume 169, Number 5 https://doi.org/10.7326/M18-07

Disparities in Acceptance of Deceased Donor Kidneys Between the United States and France and Estimated Effects of Increased US Acceptance

Aubert O, Reese PP, Audry B, Bouatou Y, Raynaud M, Viglietti D, Legendre C, Glotz D, Empana JP, Jouven X, Lefaucheur C, Jacquelinet C, Loupy A. Disparities in Acceptance of Deceased Donor Kidneys Between the United States and France and Estimated Effects of Increased US Acceptance. JAMA Intern Med. 2019 Oct 1;179(10):1365-1374. doi: 10.1001/jamainternmed.2019.2322. PMID: 31449299; PMCID: PMC6714020.

What are the harms of refusing to allow living kidney donation? An expanded view of risks and benefits

Allen MB, Abt PL, Reese PP. What are the harms of refusing to allow living kidney donation? An expanded view of risks and benefits. Am J Transplant. 2014 Mar;14(3):531-7. doi: 10.1111/ajt.12599. PMID: 24730047.

Outcomes for individuals turned down for living kidney donation

Peter P. Reese, Matthew B. Allen, Caroline Carney, Daniel Leidy, Simona Levsky, Ruchita Pendse, Adam S. Mussell, Francisca Bermudez, Shimrit Keddem, Carrie Thiessen. Published: 15 September 2018 https://doi.org/10.1111/ctr.13408

Living kidney donation: outcomes, ethics, and uncertainty

Dr Peter P Reese, MD Prof Neil Boudville, MD Prof Amit X Garg, MD Published:May 16, 2015DOI:https://doi.org/10.1016/S0140-6736(14)62484-3

Mortality and Cardiovascular Disease among Older Live Kidney Donors

Reese PP, Bloom RD, Feldman HI, Rosenbaum P, Wang W, Saynisch P, Tarsi NM, Mukherjee N, Garg AX, Mussell A, Shults J, Even-Shoshan O, Townsend RR, Silber JH. Mortality and cardiovascular disease among older live kidney donors. Am J Transplant. 2014 Aug;14(8):1853-61. doi: 10.1111/ajt.12822. Epub 2014 Jul 9. PMID: 25039276; PMCID: PMC4105987.

Kidney Transplant Outcomes for Prior Living Organ Donors

Potluri V, Harhay MN, Wilson FP, Bloom RD, Reese PP. Kidney transplant outcomes for prior living organ donors. J Am Soc Nephrol. 2015 May;26(5):1188-94. doi: 10.1681/ASN.2014030302. Epub 2014 Nov 20. PMID: 25412818; PMCID: PMC4413763.

Regulated Payments for Living Kidney Donation: An Empirical Assessment of the Ethical Concerns

Halpern SD, Raz A, Kohn R, Rey M, Asch DA, Reese P. Regulated payments for living kidney donation: an empirical assessment of the ethical concerns. Ann Intern Med. 2010 Mar 16;152(6):358-65. doi: 10.7326/0003-4819-152-6-201003160-00005. PMID: 20231566; PMCID: PMC2865248.

Reconsidering the Consequences of Using Race to Estimate Kidney Function

Eneanya ND, Yang W, Reese PP. Reconsidering the Consequences of Using Race to Estimate Kidney Function. JAMA. 2019 Jul 9;322(2):113-114. doi: 10.1001/jama.2019.5774. PMID: 31169890.

Racial disparities in preemptive waitlisting and deceased donor kidney transplantation: Ethics and solutions

Reese PP, Mohan S, King KL, Williams WW, Potluri VS, Harhay MN, Eneanya ND. Racial disparities in preemptive waitlisting and deceased donor kidney transplantation: Ethics and solutions. Am J Transplant. 2021 Mar;21(3):958-967. doi: 10.1111/ajt.16392. Epub 2020 Dec 3. PMID: 33151614.

Unique problems for the design of the first trials of transplanting porcine kidneys into humans

Reese PP, Gelb BE, Parent B. Unique problems for the design of the first trials of transplanting porcine kidneys into humans. Kidney Int. 2023 Feb;103(2):239-242. doi: 10.1016/j.kint.2022.10.009. Epub 2022 Nov 1. PMID: 36332727.

Engineering Equity Into the Promise of Xenotransplantation

Reese PP, Powe NR, Lo B. Engineering Equity Into the Promise of Xenotransplantation. Am J Kidney Dis. 2024 May;83(5):677-683. doi: 10.1053/j.ajkd.2023.09.019. Epub 2023 Nov 20. PMID: 37992981.

Promoting Safety, Transparency, and Quality in Xenotransplantation

Reese PP, Parent B. Promoting Safety, Transparency, and Quality in Xenotransplantation. Ann Intern Med. 2022 Jul;175(7):1032-1034. doi: 10.7326/M22-0539. Epub 2022 May 17. PMID: 35576589.